Drug-eluting stents are widely used to mitigate this issue but often inhibit vascular re-endothelialization, increasing the risk of thrombosis and necessitating the use of anticoagulants.

Venoplasty alone for CAS does not provide a durable solution due to the frequent reinterventions that are required. Bare-metal stent (BMS) placement has been described with variable results. In their ...

We value keeping the Device Guide up to date.

Indong Jun from KIST Europe, has developed a novel stent surface treatment technology using laser patterning. This technology promotes endothelial cell growth while inhibiting smooth muscle cell ...

Isolation and Identification of Compounds from Bioactive Extracts of Taraxacum officinale Weber ex F. H. Wigg. (Dandelion) as a Potential Source of Antibacterial Agents.

The FD was delivered using a coaxial system (6 Fr Envoy and Headway 21/27; MicroVention) over a 0.016 inch Terumo microguidewire. The pusher facilitated stent retraction and repositioning, provided no ...

One of the biggest risks for people with heart disease who are flying is developing venous thrombosis. These risks are higher if you have CAD or an implanted heart device, such as an artificial heart ...

Background While dual antiplatelet therapy (dAPT) is standard of care following carotid artery stenting (CAS), the optimal dAPT regimen and duration has not been established. Methods We canvassed a ...